![Tan Yann Chong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tan Yann Chong
Directeur Général chez Nuevocor Pte Ltd.
Postes actifs de Tan Yann Chong
Sociétés | Poste | Début | Fin |
---|---|---|---|
Nuevocor Pte Ltd.
![]() Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Directeur Général | - | - |
Fondateur | - | - |
Historique de carrière de Tan Yann Chong
Anciens postes connus de Tan Yann Chong
Sociétés | Poste | Début | Fin |
---|---|---|---|
Esco Ventures Pte Ltd.
![]() Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Private Equity Investor | - | 01/08/2022 |
Formation de Tan Yann Chong
Duke University | Undergraduate Degree |
Stanford University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Singapour | 3 |
Opérationnelle
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Esco Ventures Pte Ltd.
![]() Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Finance |
Nuevocor Pte Ltd.
![]() Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Tan Yann Chong
- Expérience